BUPROPION HYDROBROMIDE

BUPROPION HYDROBROMIDE was reported 577 times

BUPROPION HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KAYSER-FLEISCHER RING 1 0.1250
1 BRONCHIAL NEOPLASM 13 0.0956
2 EJECTION FRACTION 43 0.0740
3 SENSITISATION 56 0.0738
4 PINEAL PARENCHYMAL NEOPLASM MALIGNANT 1 0.0588
5 BRONCHIAL HAEMORRHAGE 13 0.0417
6 DECOMPRESSION SICKNESS 2 0.0392
7 ENDOMETRIAL ABLATION 13 0.0364
8 EJECTION FRACTION ABNORMAL 44 0.0359
9 NASAL TURBINATE HYPERTROPHY 13 0.0345
10 POLYCYSTIC OVARIES 53 0.0341
11 SOFT TISSUE INJURY 23 0.0304
12 POST-TRAUMATIC NECK SYNDROME 23 0.0284
13 OBSTRUCTIVE SLEEP APNOEA SYNDROME 38 0.0260
14 POLYCYSTIC OVARIAN SYNDROME 9 0.0234
15 SPUTUM PURULENT 15 0.0228
16 STERNAL FRACTURE 23 0.0186
17 MENINGITIS NEONATAL 1 0.0182
18 NEPHRECTOMY 26 0.0175
19 SECONDARY IMMUNODEFICIENCY 15 0.0123
20 RHINITIS ALLERGIC 55 0.0123
21 ENCHONDROMATOSIS 1 0.0116
22 LIBIDO INCREASED 23 0.0113
23 ELDERLY 1 0.0112
24 RUBBER SENSITIVITY 17 0.0111
25 PSYCHIATRIC DECOMPENSATION 19 0.0097
26 RHONCHI 13 0.0094
27 HOSTILITY 23 0.0090
28 PERSONALITY DISORDER 23 0.0088
29 BRONCHIAL DISORDER 13 0.0084
30 HEPATO-LENTICULAR DEGENERATION 1 0.0079
31 PSYCHOMOTOR SKILLS IMPAIRED 20 0.0076
32 DEPRESSION SUICIDAL 20 0.0058
33 FORCED EXPIRATORY VOLUME DECREASED 16 0.0056
34 DEPRESSIVE SYMPTOM 19 0.0054
35 NORMOCHROMIC ANAEMIA 1 0.0050
36 PSYCHOMOTOR RETARDATION 14 0.0050
37 TEMPERATURE REGULATION DISORDER 11 0.0049
38 FULL BLOOD COUNT ABNORMAL 51 0.0048
39 CARDIOMYOPATHY ACUTE 1 0.0046
40 TEARFULNESS 19 0.0044
41 CARPAL TUNNEL SYNDROME 56 0.0040
42 SENSITIVITY TO WEATHER CHANGE 21 0.0040
43 BLOOD TEST ABNORMAL 56 0.0040
44 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 25 0.0038
45 GRANULOMA 13 0.0038
46 NEPHROPATHY 32 0.0034
47 CONCUSSION 26 0.0034
48 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 56 0.0033
49 DRUG THERAPY 1 0.0029
50 SLEEP APNOEA SYNDROME 55 0.0029
51 ANION GAP DECREASED 1 0.0029
52 EPITHELIOID MESOTHELIOMA 1 0.0028
53 SERUM SEROTONIN INCREASED 1 0.0028
54 BREATH SOUNDS ABNORMAL 13 0.0026
55 LIMB DEFORMITY 4 0.0025
56 OBSTRUCTIVE AIRWAYS DISORDER 28 0.0025
57 DEATH OF RELATIVE 1 0.0025
58 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
59 FIBROMYALGIA 58 0.0024
60 RETINITIS 4 0.0023
61 DIVORCED 1 0.0023
62 FOETAL DEATH 11 0.0021
63 PRODUCT RESIDUE PRESENT 11 0.0020
64 NICOTINE DEPENDENCE 15 0.0019
65 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
66 MORNING SICKNESS 1 0.0018
67 HYPOTHYROIDISM 57 0.0018
68 AFFECTIVE DISORDER 14 0.0018
69 BLOODY DISCHARGE 2 0.0017
70 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 30 0.0017
71 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
72 GRUNTING 1 0.0017
73 RHINITIS 13 0.0016
74 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
75 COMPULSIONS 1 0.0015
76 WHEEZING 85 0.0014
77 FOOD ALLERGY 11 0.0014
78 DRUG-DISEASE INTERACTION 1 0.0014
79 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
80 CRITICAL ILLNESS 1 0.0013
81 EXPOSURE VIA BREAST MILK 5 0.0013
82 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 89 0.0012
83 MIDDLE INSOMNIA 23 0.0012
84 HYPOVENTILATION 4 0.0012
85 COELIAC DISEASE 12 0.0012
86 RIB FRACTURE 25 0.0012
87 RENAL DISORDER 56 0.0012
88 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
89 BONE EROSION 4 0.0011
90 MUSCLE TWITCHING 26 0.0011
91 BODY TEMPERATURE INCREASED 23 0.0011
92 INDURATION 2 0.0011
93 POOR QUALITY SLEEP 24 0.0011
94 PARANOIA 19 0.0011
95 PRESCRIBED OVERDOSE 21 0.0011
96 RAYNAUD'S PHENOMENON 1 0.0011
97 GASTROOESOPHAGEAL REFLUX DISEASE 85 0.0011
98 PARTNER STRESS 1 0.0010
99 ASTHMA 117 0.0010
100 CORRECTIVE LENS USER 1 0.0010
101 RESPIRATORY DISORDER 30 0.0010
102 BURSITIS 12 0.0010
103 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
104 SINUS TACHYCARDIA 14 0.0010
105 PRODUCT COATING ISSUE 1 0.0010
106 TROPONIN INCREASED 7 0.0009
107 SEDATION 24 0.0009
108 PILOERECTION 1 0.0009
109 ESSENTIAL TREMOR 1 0.0009
110 ADMINISTRATION SITE PAIN 1 0.0009
111 ANKLE FRACTURE 13 0.0008
112 BURNING SENSATION 58 0.0008
113 ILEOSTOMY 2 0.0008
114 INFUSION SITE IRRITATION 1 0.0008
115 MEDICATION RESIDUE 2 0.0008
116 ABDOMINAL OPERATION 1 0.0008
117 FEELINGS OF WORTHLESSNESS 1 0.0008
118 LIP INJURY 1 0.0008
119 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
120 FEELING GUILTY 1 0.0008
121 HYPOVITAMINOSIS 1 0.0008
122 NIGHTMARE 26 0.0008
123 GLYCOSURIA 1 0.0007
124 IMMUNODEFICIENCY 11 0.0007
125 CARBON DIOXIDE INCREASED 1 0.0007
126 FOOT DEFORMITY 8 0.0007
127 RHEUMATOID FACTOR POSITIVE 4 0.0007
128 JUDGEMENT IMPAIRED 1 0.0007
129 PSYCHOTIC DISORDER 19 0.0006
130 SUBSTANCE USE 1 0.0006
131 BACTERIAL VAGINOSIS 1 0.0006
132 CARDIAC DISORDER 56 0.0006
133 EXPOSURE TO CHEMICAL POLLUTION 1 0.0006
134 EROSIVE OESOPHAGITIS 1 0.0006
135 INSURANCE ISSUE 9 0.0006
136 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
137 BLADDER NEOPLASM 1 0.0006
138 CERVICAL SPINAL STENOSIS 1 0.0006
139 PUPIL FIXED 1 0.0006
140 ROTATOR CUFF REPAIR 1 0.0006
141 INFUSION SITE DISCHARGE 1 0.0006
142 FANCONI SYNDROME ACQUIRED 1 0.0006
143 IMPRISONMENT 1 0.0006
144 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
145 EXOSTOSIS 5 0.0005
146 VITRITIS 1 0.0005
147 PERICARDITIS 9 0.0005
148 HYPOREFLEXIA 1 0.0005
149 COMPULSIVE SHOPPING 1 0.0005
150 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
151 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
152 ADVERSE EVENT 43 0.0005
153 IRRITABILITY 28 0.0005
154 LUPUS-LIKE SYNDROME 4 0.0004
155 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
156 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
157 VERTIGO 26 0.0004
158 MAJOR DEPRESSION 3 0.0004
159 BREATH ODOUR 1 0.0004
160 HAEMATOLOGICAL INFECTION 1 0.0004
161 FEELING HOT 25 0.0004
162 RETINAL TEAR 1 0.0004
163 MULTIPLE DRUG OVERDOSE 2 0.0004
164 INFREQUENT BOWEL MOVEMENTS 1 0.0004
165 TACHYARRHYTHMIA 1 0.0004
166 ABDOMINAL INFECTION 1 0.0004
167 PHLEBITIS 2 0.0004
168 TRISMUS 2 0.0004
169 HERNIA REPAIR 1 0.0004
170 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
171 JOINT DISLOCATION 4 0.0004
172 HYPERTENSION 80 0.0004
173 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
174 AREFLEXIA 1 0.0004
175 JOINT RANGE OF MOTION DECREASED 5 0.0004
176 GAMBLING DISORDER 1 0.0004
177 SINUS CONGESTION 5 0.0004
178 ASPIRATION 4 0.0004
179 DRUG INTOLERANCE 35 0.0004
180 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
181 DRUG INTERACTION 56 0.0004
182 HYPERVENTILATION 2 0.0003
183 DEPRESSION 78 0.0003
184 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
185 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
186 EXPOSURE DURING PREGNANCY 21 0.0003
187 DRUG WITHDRAWAL SYNDROME NEONATAL 5 0.0003
188 HYPERHIDROSIS 43 0.0003
189 CEREBROVASCULAR DISORDER 1 0.0003
190 LOSS OF EMPLOYMENT 1 0.0003
191 PEMPHIGUS 4 0.0003
192 INFUSION SITE PRURITUS 1 0.0003
193 POLYMYALGIA RHEUMATICA 1 0.0003
194 CONVULSION 18 0.0003
195 DYSGEUSIA 23 0.0003
196 FACET JOINT SYNDROME 1 0.0003
197 NODULE 4 0.0003
198 HOSPITALISATION 47 0.0003
199 ANXIETY 87 0.0003
200 HAND DEFORMITY 4 0.0003
201 BODY TEMPERATURE DECREASED 3 0.0003
202 INFUSION SITE HAEMORRHAGE 1 0.0003
203 NEPHRITIS 1 0.0003
204 POSTOPERATIVE WOUND INFECTION 2 0.0003
205 SUICIDAL IDEATION 27 0.0003
206 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
207 DYSPEPSIA 29 0.0003
208 B-CELL LYMPHOMA 1 0.0003
209 MIGRAINE 28 0.0003
210 RESPIRATION ABNORMAL 2 0.0003
211 TACHYPHRENIA 1 0.0003
212 HYPOPNOEA 1 0.0003
213 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
214 GALLBLADDER DISORDER 5 0.0003
215 FRUSTRATION 1 0.0003
216 CAROTID ARTERY OCCLUSION 1 0.0003
217 NASAL CONGESTION 16 0.0003
218 ALCOHOL USE 1 0.0003
219 MATERNAL EXPOSURE DURING PREGNANCY 24 0.0003
220 FLUSHING 27 0.0003
221 FEELING JITTERY 5 0.0003
222 GASTRIC INFECTION 1 0.0003
223 CLAVICLE FRACTURE 1 0.0003
224 FLUID RETENTION 13 0.0003
225 HYPERSENSITIVITY 47 0.0003
226 HYPERPHAGIA 1 0.0003
227 SKIN PAPILLOMA 1 0.0002
228 HOMICIDAL IDEATION 1 0.0002
229 FEEDING DISORDER 5 0.0002
230 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
231 CONTUSION 23 0.0002
232 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
233 SKIN PLAQUE 2 0.0002
234 HEPATIC ENZYME INCREASED 16 0.0002
235 RETCHING 5 0.0002
236 SHOULDER OPERATION 1 0.0002
237 OXYGEN SATURATION DECREASED 13 0.0002
238 CHAPPED LIPS 1 0.0002
239 RASH ERYTHEMATOUS 11 0.0002
240 EPILEPSY 7 0.0002
241 TONGUE DISCOLOURATION 1 0.0002
242 GROIN PAIN 2 0.0002
243 HYPOAESTHESIA 34 0.0002
244 INFUSION RELATED REACTION 15 0.0002
245 ABDOMINAL ABSCESS 1 0.0002
246 HERPES ZOSTER 13 0.0002
247 ABORTION SPONTANEOUS 9 0.0002
248 SYNOVITIS 4 0.0002
249 MEMORY IMPAIRMENT 30 0.0002
250 INCREASED TENDENCY TO BRUISE 2 0.0002
251 NEPHROGENIC ANAEMIA 1 0.0002
252 WOUND 6 0.0002
253 ROSACEA 1 0.0002
254 FEELING OF DESPAIR 1 0.0002
255 HEPATIC CIRRHOSIS 4 0.0002
256 OSTEOARTHRITIS 9 0.0002
257 MEDICATION RESIDUE PRESENT 1 0.0002
258 HEADACHE 130 0.0002
259 STILLBIRTH 1 0.0002
260 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
261 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
262 INABILITY TO AFFORD MEDICATION 2 0.0002
263 APPLICATION SITE SWELLING 1 0.0002
264 TREMOR 33 0.0002
265 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
266 DRUG TOLERANCE 1 0.0002
267 SLUGGISHNESS 2 0.0002
268 INCREASED UPPER AIRWAY SECRETION 1 0.0002
269 MUSCULOSKELETAL CHEST PAIN 3 0.0002
270 TENDERNESS 2 0.0002
271 MALABSORPTION 1 0.0002
272 FOOD POISONING 1 0.0002
273 INFECTION 27 0.0002
274 BLOOD PRESSURE INCREASED 28 0.0002
275 WEIGHT INCREASED 41 0.0002
276 NONSPECIFIC REACTION 1 0.0002
277 ASTHENOPIA 1 0.0002
278 VIRAL INFECTION 6 0.0002
279 HEART RATE ABNORMAL 1 0.0002
280 GLOSSODYNIA 4 0.0002
281 ORAL PAIN 4 0.0002
282 GENERALISED ERYTHEMA 1 0.0002
283 NEUTROPHILIA 1 0.0002
284 METABOLIC DISORDER 1 0.0002
285 SEXUAL DYSFUNCTION 2 0.0002
286 CATARACT OPERATION 1 0.0002
287 SYMPTOM RECURRENCE 1 0.0002
288 SINUSITIS 17 0.0002
289 NO THERAPEUTIC RESPONSE 2 0.0002
290 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
291 PRE-EXISTING CONDITION IMPROVED 1 0.0002
292 MULTIPLE INJURIES 1 0.0002
293 RHEUMATOID ARTHRITIS 18 0.0002
294 TACHYCARDIA 14 0.0002
295 JOINT SWELLING 19 0.0002
296 COUGH 44 0.0002
297 PRODUCT SUBSTITUTION ISSUE 9 0.0002
298 DIPLOPIA 4 0.0002
299 ABDOMINAL DISTENSION 16 0.0002
300 JOINT STIFFNESS 4 0.0002
301 DYSGRAPHIA 1 0.0002
302 PRODUCT FORMULATION ISSUE 1 0.0002
303 EAR INFECTION 4 0.0002
304 CHOLECYSTITIS CHRONIC 1 0.0001
305 SOMNOLENCE 30 0.0001
306 INFARCTION 1 0.0001
307 OSTEOPOROSIS 6 0.0001
308 DYSPNOEA 82 0.0001
309 TREATMENT FAILURE 12 0.0001
310 AUTOIMMUNE HEPATITIS 1 0.0001
311 MASS 2 0.0001
312 DEFAECATION URGENCY 1 0.0001
313 CONSTIPATION 31 0.0001
314 MYALGIA 24 0.0001
315 HAND FRACTURE 1 0.0001
316 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
317 WEIGHT DECREASED 39 0.0001
318 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
319 APATHY 2 0.0001
320 INTENTIONAL PRODUCT MISUSE 12 0.0001
321 MUSCULOSKELETAL STIFFNESS 12 0.0001
322 HYPOPHOSPHATAEMIA 1 0.0001
323 FEELING DRUNK 1 0.0001
324 DUODENAL ULCER PERFORATION 1 0.0001
325 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
326 ECONOMIC PROBLEM 2 0.0001
327 PRODUCT AVAILABILITY ISSUE 3 0.0001
328 DISCOMFORT 8 0.0001
329 DISSOCIATION 1 0.0001
330 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
331 PALPITATIONS 15 0.0001
332 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
333 THERAPY INTERRUPTED 9 0.0001
334 OBESITY 2 0.0001
335 BLOOD DISORDER 1 0.0001
336 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
337 MOVEMENT DISORDER 4 0.0001
338 DYSKINESIA 5 0.0001
339 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
340 MANIA 2 0.0001
341 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
342 BLOOD PRESSURE DECREASED 8 0.0001
343 INFUSION SITE ERYTHEMA 1 0.0001
344 FACE OEDEMA 2 0.0001
345 CANDIDA INFECTION 2 0.0001
346 ANGER 4 0.0001
347 SKIN HYPERPIGMENTATION 1 0.0001
348 INFLAMMATION 6 0.0001
349 MUSCLE STRAIN 1 0.0001
350 PSORIASIS 15 0.0001
351 THIRST 2 0.0001
352 GASTROINTESTINAL INFECTION 1 0.0001
353 CRYING 4 0.0001
354 OPTIC NEURITIS 1 0.0001
355 C-REACTIVE PROTEIN INCREASED 4 0.0001
356 OVARIAN CANCER 1 0.0001
357 GRAND MAL CONVULSION 1 0.0001
358 INFLUENZA 12 0.0001
359 FLANK PAIN 1 0.0001
360 LACERATION 1 0.0001
361 SPUTUM DISCOLOURED 1 0.0001
362 INCREASED APPETITE 2 0.0001
363 RASH 45 0.0001
364 VITREOUS FLOATERS 1 0.0001
365 ARTHRITIS 8 0.0001
366 THERAPY CHANGE 1 0.0001
367 DISABILITY 2 0.0001
368 LIGAMENT SPRAIN 1 0.0001
369 HYPOTONIA 1 0.0001
370 SALIVARY HYPERSECRETION 1 0.0001
371 DRY THROAT 1 0.0001
372 MOBILITY DECREASED 7 0.0001
373 PETECHIAE 1 0.0001
374 PRODUCT ODOUR ABNORMAL 1 0.0001
375 FOLLICULITIS 1 0.0001
376 MOOD SWINGS 3 0.0001
377 IMPAIRED WORK ABILITY 2 0.0001
378 DECREASED ACTIVITY 1 0.0001
379 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
380 BIPOLAR DISORDER 1 0.0001
381 SKIN LACERATION 1 0.0001
382 FATIGUE 71 0.0001
383 PRODUCT USE ISSUE 17 0.0001
384 DIZZINESS 45 0.0001
385 THROMBOCYTOPENIA 10 0.0001
386 REBOUND EFFECT 1 0.0001
387 TINNITUS 4 0.0001
388 NEOPLASM 1 0.0001
389 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
390 MUSCLE RIGIDITY 1 0.0001
391 WRIST FRACTURE 1 0.0001
392 LOCALISED INFECTION 2 0.0001
393 BACK PAIN 19 0.0001
394 ABDOMINAL PAIN 19 0.0001
395 TENDON RUPTURE 1 0.0001
396 APPLICATION SITE IRRITATION 1 0.0001
397 CELLULITIS 4 0.0001
398 ROTATOR CUFF SYNDROME 1 0.0001
399 INFUSION SITE PAIN 1 0.0001
400 ANHEDONIA 2 0.0001
401 INCORRECT PRODUCT STORAGE 1 0.0001
402 ANKYLOSING SPONDYLITIS 1 0.0001
403 TOOTH INFECTION 1 0.0001
404 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
405 FEAR 2 0.0001
406 DISTURBANCE IN ATTENTION 4 0.0001
407 GINGIVAL BLEEDING 1 0.0001
408 ACUTE HEPATIC FAILURE 1 0.0001
409 LUNG NEOPLASM MALIGNANT 3 0.0001
410 PERIPHERAL COLDNESS 1 0.0001
411 ABNORMAL DREAMS 2 0.0001
412 COORDINATION ABNORMAL 1 0.0001
413 BLISTER 4 0.0001
414 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
415 SEASONAL ALLERGY 1 0.0001
416 INTENTIONAL DOSE OMISSION 2 0.0001
417 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
418 HYPERSOMNIA 2 0.0001
419 CARDIOGENIC SHOCK 1 0.0001
420 MENTAL DISORDER 3 0.0001
421 HYPOKINESIA 1 0.0001
422 GASTROENTERITIS 1 0.0001
423 DYSSTASIA 2 0.0001
424 ERYTHEMA 14 0.0001
425 PULMONARY MASS 1 0.0001
426 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
427 HYPOAESTHESIA ORAL 1 0.0001
428 OFF LABEL USE 58 0.0001
429 OSTEOPENIA 1 0.0001
430 VISION BLURRED 9 0.0001
431 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
432 NASOPHARYNGITIS 12 0.0001
433 PHARYNGEAL OEDEMA 1 0.0001
434 THYROID DISORDER 1 0.0001
435 EMOTIONAL DISORDER 2 0.0001
436 DELUSION 1 0.0001
437 CYANOSIS 1 0.0001
438 PRODUCT USE COMPLAINT 1 0.0001
439 PNEUMOTHORAX 1 0.0001
440 MYOCARDIAL INFARCTION 11 0.0001
441 PRODUCTIVE COUGH 3 0.0001
442 SCIATICA 1 0.0001
443 CONDITION AGGRAVATED 19 0.0001
444 NIGHT SWEATS 2 0.0001
445 PAIN 38 0.0001
446 DRY MOUTH 5 0.0001
447 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
448 PHOTOSENSITIVITY REACTION 1 0.0001
449 OVERDOSE 13 0.0001
450 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
451 INSOMNIA 16 0.0001
452 LEUKOPENIA 3 0.0001
453 SKIN DISORDER 2 0.0001
454 AGGRESSION 3 0.0001
455 BLOOD UREA INCREASED 1 0.0001
456 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
457 HEMIPARESIS 1 0.0001
458 CIRCULATORY COLLAPSE 1 0.0001
459 METRORRHAGIA 1 0.0001
460 CHEST DISCOMFORT 6 0.0001
461 THERAPY CESSATION 3 0.0001
462 FEELING ABNORMAL 14 0.0001
463 SCAR 1 0.0001
464 GASTRIC DISORDER 2 0.0001
465 NAUSEA 46 0.0001
466 PYREXIA 20 0.0001
467 NERVOUSNESS 3 0.0001
468 SPEECH DISORDER 3 0.0001
469 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
470 HEAD DISCOMFORT 1 0.0001
471 ADVERSE DRUG REACTION 5 0.0001
472 GASTROENTERITIS VIRAL 1 0.0001
473 LEUKOCYTOSIS 1 0.0001
474 PANIC ATTACK 2 0.0001
475 TREATMENT NONCOMPLIANCE 3 0.0001
476 END STAGE RENAL DISEASE 1 0.0001
477 AGITATION 4 0.0001
478 OROPHARYNGEAL PAIN 5 0.0001
479 THINKING ABNORMAL 1 0.0001
480 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
481 PHOTOPHOBIA 1 0.0001
482 BLOOD SODIUM DECREASED 1 0.0001
483 FOOT FRACTURE 1 0.0001
484 BLOOD URINE PRESENT 1 0.0001
485 DIARRHOEA 34 0.0001
486 CHRONIC KIDNEY DISEASE 4 0.0001
487 GASTRIC ULCER 1 0.0001
488 SEROTONIN SYNDROME 1 0.0001
489 LOWER LIMB FRACTURE 1 0.0001
490 DECREASED APPETITE 12 0.0001
491 EAR PAIN 1 0.0001
492 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
493 CHOKING 1 0.0001
494 PAIN IN EXTREMITY 15 0.0001
495 BLOOD PRESSURE ABNORMAL 1 0.0001
496 COMPLICATION OF DEVICE INSERTION 1 0.0001
497 UPPER LIMB FRACTURE 1 0.0001
498 PRESCRIBED UNDERDOSE 1 0.0001
499 DRUG INEFFECTIVE 66 0.0001
500 EXTRA DOSE ADMINISTERED 2 0.0000
501 OEDEMA PERIPHERAL 6 0.0000
502 INJECTION SITE WARMTH 1 0.0000
503 VISUAL IMPAIRMENT 6 0.0000
504 POLLAKIURIA 2 0.0000
505 INTENTIONAL DRUG MISUSE 1 0.0000
506 DERMATITIS 1 0.0000
507 ABDOMINAL DISCOMFORT 8 0.0000
508 EATING DISORDER 1 0.0000
509 LOSS OF CONSCIOUSNESS 6 0.0000
510 RHINORRHOEA 3 0.0000
511 BALANCE DISORDER 4 0.0000
512 DEVICE EXPULSION 3 0.0000
513 PRURITUS GENERALISED 1 0.0000
514 PRODUCT DISPENSING ERROR 1 0.0000
515 ARTHRALGIA 19 0.0000
516 STEVENS-JOHNSON SYNDROME 1 0.0000
517 INJECTION SITE PRURITUS 3 0.0000
518 PRODUCT QUALITY ISSUE 6 0.0000
519 BLOOD CHOLESTEROL INCREASED 2 0.0000
520 SLEEP DISORDER 3 0.0000
521 DRUG DOSE OMISSION 7 0.0000
522 DISEASE RECURRENCE 2 0.0000
523 MULTIPLE SCLEROSIS 2 0.0000
524 HYPOGLYCAEMIA 2 0.0000
525 HEART RATE INCREASED 4 0.0000
526 INJECTION SITE ERYTHEMA 5 0.0000
527 EPISTAXIS 3 0.0000
528 DRY EYE 2 0.0000
529 HOT FLUSH 3 0.0000
530 HYPOPHAGIA 1 0.0000
531 MALAISE 17 0.0000
532 EXPOSURE VIA SKIN CONTACT 1 0.0000
533 RESPIRATORY TRACT INFECTION 1 0.0000
534 DEAFNESS 1 0.0000
535 APPLICATION SITE ERYTHEMA 1 0.0000
536 GASTRITIS 1 0.0000
537 DERMATITIS ATOPIC 2 0.0000
538 RENAL FAILURE 5 0.0000
539 CARDIAC FAILURE 3 0.0000
540 MENSTRUATION IRREGULAR 1 0.0000
541 JAUNDICE 1 0.0000
542 PNEUMONIA 12 0.0000
543 THROAT TIGHTNESS 1 0.0000
544 RESPIRATORY ARREST 1 0.0000
545 DRUG ABUSE 3 0.0000
546 MENTAL STATUS CHANGES 1 0.0000
547 NECK PAIN 2 0.0000
548 DEMENTIA 1 0.0000
549 ALOPECIA 7 0.0000
550 HYPONATRAEMIA 2 0.0000
551 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
552 ANGINA PECTORIS 1 0.0000
553 LETHARGY 2 0.0000
554 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
555 DYSPHONIA 2 0.0000
556 BONE PAIN 2 0.0000
557 SURGERY 2 0.0000
558 ASCITES 1 0.0000
559 BLOOD POTASSIUM DECREASED 1 0.0000
560 PREMATURE BABY 1 0.0000
561 SUICIDE ATTEMPT 2 0.0000
562 INJECTION SITE RASH 1 0.0000
563 DRUG ADMINISTRATION ERROR 1 0.0000
564 PERIPHERAL SWELLING 5 0.0000
565 ASTHENIA 12 0.0000
566 DYSPHAGIA 3 0.0000
567 CYSTITIS 1 0.0000
568 GAIT DISTURBANCE 6 0.0000
569 AMNESIA 2 0.0000
570 OSTEONECROSIS 1 0.0000
571 STAPHYLOCOCCAL INFECTION 1 0.0000
572 VISUAL ACUITY REDUCED 1 0.0000
573 URINARY RETENTION 1 0.0000
574 GAIT INABILITY 1 0.0000
575 HYPOTENSION 6 0.0000
576 TYPE 2 DIABETES MELLITUS 1 0.0000
577 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
578 DELIRIUM 1 0.0000
579 LYMPHADENOPATHY 1 0.0000
580 VOMITING 13 0.0000
581 RESTLESSNESS 1 0.0000
582 DYSURIA 1 0.0000
583 EYE SWELLING 1 0.0000
584 DYSPNOEA EXERTIONAL 1 0.0000
585 MUSCULAR WEAKNESS 3 0.0000
586 COLITIS 1 0.0000
587 INCORRECT DOSE ADMINISTERED 6 0.0000
588 ACUTE KIDNEY INJURY 4 0.0000
589 PARAESTHESIA 4 0.0000
590 PSORIATIC ARTHROPATHY 1 0.0000
591 NEUTROPHIL COUNT DECREASED 1 0.0000
592 FALL 8 0.0000
593 RHABDOMYOLYSIS 1 0.0000
594 ROAD TRAFFIC ACCIDENT 1 0.0000
595 URTICARIA 4 0.0000
596 CEREBROVASCULAR ACCIDENT 4 0.0000
597 RENAL FAILURE ACUTE 1 0.0000
598 VAGINAL HAEMORRHAGE 1 0.0000
599 LIVER DISORDER 1 0.0000
600 DRY SKIN 3 0.0000
601 COLITIS ULCERATIVE 1 0.0000
602 NEPHROLITHIASIS 1 0.0000
603 SKIN DISCOLOURATION 1 0.0000
604 COGNITIVE DISORDER 1 0.0000
605 NEUROPATHY PERIPHERAL 2 0.0000
606 ATRIAL FIBRILLATION 2 0.0000
607 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
608 INJECTION SITE PAIN 6 0.0000
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
610 ECZEMA 1 0.0000
611 MUSCULOSKELETAL PAIN 1 0.0000
612 PANCREATITIS 1 0.0000
613 DEPRESSED MOOD 1 0.0000
614 DRUG EFFECT DECREASED 1 0.0000
615 CONFUSIONAL STATE 3 0.0000
616 OEDEMA 1 0.0000
617 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
618 HAEMATOCHEZIA 1 0.0000
619 ANAPHYLACTIC REACTION 1 0.0000
620 ARTHROPATHY 1 0.0000
621 MEDICATION ERROR 1 0.0000
622 EYE PAIN 1 0.0000
623 URINARY TRACT INFECTION 3 0.0000
624 EYE IRRITATION 1 0.0000
625 SEIZURE 2 0.0000
626 COVID-19 3 0.0000
627 NO ADVERSE EVENT 3 0.0000
628 EMOTIONAL DISTRESS 2 0.0000
629 THERAPEUTIC RESPONSE DECREASED 1 0.0000
630 PRURITUS 6 0.0000
631 SWELLING FACE 1 0.0000
632 PRODUCT DOSE OMISSION 1 0.0000
633 DEHYDRATION 2 0.0000
634 ABDOMINAL PAIN UPPER 3 0.0000
635 INJECTION SITE REACTION 1 0.0000
636 DEVICE MALFUNCTION 1 0.0000
637 INJURY 1 0.0000
638 PRODUCT DOSE OMISSION ISSUE 4 0.0000
639 BRONCHITIS 1 0.0000
640 UNEVALUABLE EVENT 1 0.0000
641 ACNE 1 0.0000
642 DIABETES MELLITUS 1 0.0000
643 INJECTION SITE SWELLING 1 0.0000
644 CARDIAC ARREST 1 0.0000
645 COMPLETED SUICIDE 1 0.0000
646 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
647 TOXICITY TO VARIOUS AGENTS 2 0.0000
648 DRUG WITHDRAWAL SYNDROME 1 0.0000
649 MUSCLE SPASMS 2 0.0000
650 BREAST CANCER 1 0.0000
651 SWELLING 1 0.0000
652 SYNCOPE 1 0.0000
653 ILLNESS 1 0.0000
654 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
655 HAEMORRHAGE 1 0.0000
656 PLATELET COUNT DECREASED 1 0.0000
657 SEPSIS 1 0.0000
658 CHILLS 1 0.0000
659 DEATH 7 0.0000
660 NEUTROPENIA 1 0.0000
661 DRUG DEPENDENCE 1 0.0000
662 CHEST PAIN 1 0.0000
663 ANAEMIA 1 0.0000